Search

Search Constraints

You searched for: Author/Creator Marzinke, Mark A.

Search Results

1. A phase 1 randomized placebo-controlled safety and pharmacokinetic trial of a tenofovir disoproxil fumarate vaginal ring. (13th March 2016)

2. A phase 1 randomized placebo-controlled safety and pharmacokinetic trial of a tenofovir disoproxil fumarate vaginal ring. (13th March 2016)

3. A Phase 1 Trial to Assess the Safety, Acceptability, Pharmacokinetics, and Pharmacodynamics of a Novel Dapivirine Vaginal Film. (15th April 2016)

4. A population pharmacokinetic model based on HPTN 077 of long‐acting injectable cabotegravir for HIV PrEP. Issue 10 (14th August 2022)

5. Antiretroviral Drug Use and HIV Drug Resistance Among HIV-Infected Black Men Who Have Sex With Men: HIV Prevention Trials Network 061. (1st August 2015)

6. Antiretroviral Drug Use in a Cross-Sectional Population Survey in Africa: NIMH Project Accept (HPTN 043). (1st February 2017)

7. Bone changes with candidate PrEP regimens containing tenofovir disoproxil fumarate and/or maraviroc and/or emtricitabine in US men and women: HPTN 069/ACTG A5305. (13th November 2021)

8. Brief Report: Hormonal Contraception Use and Cabotegravir Pharmacokinetics in HIV-Uninfected Women Enrolled in HPTN 077. (1st September 2020)

9. Brief Report: Medication Sharing Is Rare Among African HIV-1 Serodiscordant Couples Enrolled in an Efficacy Trial of Oral Pre-exposure Prophylaxis (PrEP) for HIV-1 Prevention. (1st June 2017)

10. Characterization of HIV Seroconverters in a TDF/FTC PrEP Study: HPTN 067/ADAPT. (1st July 2017)